Advice for first time buyers ahead of the new financial year
Kier Living break down some of the crucial details that first time buyers need to consider before buying a home ahead of the new financial year.
Hong Kong approves the Sinovac COVID vaccine for use
The Sinovac COVID vaccine was revealed to be working at 50.4% efficacy by the Butantan Institute last month, but new data suggests that this could actually be 62%.
UK government to launch new high risk research agency
The UK government will launch a new independent research body to fund high-risk, high-reward scientific research called the Advanced Research & Invention Agency (ARIA).
Can employers legally enforce compulsory vaccination on their workers?
Debbie Sadler, senior associate on the employment team at Blaser Mills Law, discusses whether or not employers are legally entitled to enforce compulsory COVID-19 vaccination on their workers.
NASA’s Perseverance rover successfully lands on Mars
NASA’s Perseverance rover will make its final descent to Mars on the 18th of February 2021 at approximately 12:55 p.m. PST.
The spike mutation makes COVID eight times more infectious
The spike protein mutation found in the Brazilian, South African and UK variants of COVID-19 can make the virus eight times more infectious.
Irregular sleep schedule increases risk of depression
A new study has found that having an irregular sleep schedule can increase the risk of bad moods and depression.
Student nurse applications increase by one third in 2021
After COVID-19 hit the NHS, the public health crisis highlighted the poignant and essential nature of nursing work - leading to student nurse applications increasing to 60,130 for 2021.
New research studies to tackle Long COVID in the community
Four new research studies looking into Long COVID in the community will receive funding worth £18.5 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
Can an mRNA vaccine be used to cure some types of cancer?
COVID brought the idea of mRNA vaccines to the attention of the world - now, cancer researchers are investigating how a similar vaccine could stop tumours in a single treatment.
Pfizer vaccine can still prevent death from the South African mutation
The Pfizer and BioNTech vaccine appears to be significantly less efficient against the South African mutation, but can still stop hosts from experiencing severe COVID and dying from the virus.
NASA’s Perseverance rover searches for life on Mars
NASA's Perservance rover will begin its descent to Mars today (18th February) in search of microbial life on the Red Planet.
REACT study: COVID cases in hospitals “higher than at the peak of the first...
New data from the REACT study finds that the number of COVID cases in hospitals is higher than it was in April 2020, but that infection rates are substantially decreasing across the country.
UK receives ethics approval for first coronavirus human challenge study
The UK has received approval from the clinical trials ethics body for the world's first coronavirus human challenge study.
European Commission approves second Moderna contract for 300m vaccines
The European Commission has approved a second contract with Moderna to secure an additional 300 million vaccine doses.
Marmot Review 2020: “Regressive” cuts hit most deprived areas
We have the essentials of the Marmot Review 2020 for you, including recommended policy measures to tackle health inequalities.
Suicide rates for young women are increasing in Japan
For one decade, Japan worked to bring down suicide rates across the country - now, COVID-19 threatens to reverse this progress by creating a new category of people who are vulnerable.
Energy: Public sector has the power to drive the net-zero transition
Ahead of a new report, the Association for Decentralised Energy’s Chief Strategic Advisor Joanne Wade, examines the role of the public sector in leading the energy transition to net-zero.
Commission launches “HERA Incubator” project to fight COVID mutations
The European Commission today (17 February) launched the "HERA Incubator", as both a "blueprint" for long-term health emergencies and a way to stop COVID-19 mutations.
Suffering with Premature Ovarian Insufficiency (POI) in the workplace
Dr Ghazala Aziz-Scott, a specialist in Women’s health at The Marion Gluck Clinic, explores how Premature Ovarian Insufficiency (POI) can affect working women and how they can discuss this problem with their employer.
